Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman: Podcast available at www.medtechmatters.

Abstract:
Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that it has elected Patrick Langlois as chairman of its non-executive board, effective immediately.

Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman: Podcast available at www.medtechmatters.

PARIS, France | Posted on May 13th, 2008

Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that it has elected Patrick Langlois as chairman of its non-executive board, effective immediately.

Since March 1, 2005, Mr. Langlois has served as a General Partner with PJL CONSEILS, a consulting firm specializing in strategy, corporate development, and M&A activities for healthcare companies. Prior to PJL, he was vice chairman of the management board and chief financial officer at Aventis (created by the merger of Rhône-Poulenc and Hoechst) from May 2002 to September 2004, and executive vice president and chief financial officer of Aventis from December 1999 to May 2002.

At Aventis, Mr. Langlois was responsible for finance, corporate development, and supervision of the company's dermatology, protein therapeutics, and animal health businesses. Earlier in his career, he was employed by Rhône-Poulenc Group from 1975 to 1999, most recently as chief financial officer and member of the executive committee. In addition to Nanobiotix, Mr. Langlois also is a board member of Shire Pharmaceuticals (UK), Scynexis (USA), and Exonhit Therapeutics (France). In addition, Mr. Langlois has served as a senior advisor to JP Morgan Healthcare since December 2006.

"The addition of such an accomplished industry veteran as Patrick Langlois bears strong testimony to the significant opportunity ahead of Nanobiotix," said Laurent Levy, Ph.D., chief executive officer of Nanobiotix. "We look forward to reaping the benefits of Patrick's considerable talent and abundant experience related to accessing the capital markets and building strong strategic partnerships."

"The Company's NanoXray platform has the potential to be a dramatic innovation in cancer therapy, based on a technology that is designed to allow destruction of cancer cells only," added Patrick Langlois. "I am very proud to be part of this important mission."

####

About Nanobiotix
Nanobiotix is an emerging nanomedicine company combining dramatic advances in nanotechnology and molecular biology to develop nanoXray™— a technology platform

that is expected to be turned ‘on’ and ‘off’ outside the body to selectively treat a variety of cancers safely and noninvasively. Use of NanoXray is intended to resolve radiation therapy’s biggest drawback: destruction of healthy tissue and its subsequent deleterious side effects when a high dose of x-ray is necessary. The core of a nanoXray nanoparticle is an inactive and inert substance—not a drug—that can subsequently be activated in order to locally (intratumor) increase the dose of x-ray, which is then expected to lead to higher efficiency. After nanoXray nanoparticles accumulate in the target tissues, a standard x-ray is applied that is intended to generate a local therapeutic effect, designed to destroy only the targeted tumor cells. This mechanism suggests total control of the intended therapeutic effect.

For more information, please click here

Contacts:
Ronald Trahan
Ronald Trahan Associates Inc.
508-359-4005, x108

Copyright © PRWeb™

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

So, near and yet so far: Stable HGNs for Raman April 1st, 2015

Two-dimensional dirac materials: Structure, properties, and rarity April 1st, 2015

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Light-powered gyroscope is world's smallest: Promises a powerful spin on navigation April 1st, 2015

Nanomedicine

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Announcements

So, near and yet so far: Stable HGNs for Raman April 1st, 2015

Two-dimensional dirac materials: Structure, properties, and rarity April 1st, 2015

3-D neural structure guided with biocompatible nanofiber scaffolds and hydrogels April 1st, 2015

Light-powered gyroscope is world's smallest: Promises a powerful spin on navigation April 1st, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanofilm Appoints Senior Sales/Marketing Executives: Don Tecco, Director of Optical Sales, North America and Rex Talbott, Business Director Optical Products March 23rd, 2015

KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015

SouthWest Nanotechnologies CEO Dave Arthur Appointed to the Board of Affiliates of Rice University Professional Science Master’s Program February 13th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE